Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Suzetrigine in Total Hip Arthroplasty — Stella

Home/Total Hip Arthroplasty (THA)/Suzetrigine in Total Hip Arthroplasty

View on ClinicalTrials.gov

Recruiting

Back to Total Hip Arthroplasty (THA) trials

Suzetrigine in Total Hip Arthroplasty

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

Hospital for Special Surgery, New York, New York

Key details

Phase

Large-scale testing

Sponsor

Hospital for Special Surgery, New York

Enrollment target

~210 participants

Started

November 2025

Primary completion

November 2027

Age range

18 Years – 80 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.